Effettuare il login Iscriviti gratis

Edesa Biotech Margine lordo

Cos'è Margine lordo di Edesa Biotech?

Margine lordo di Edesa Biotech, Inc. è 62,240.00%

Qual è la definizione di Margine lordo?



Il margine lordo è la differenza tra entrate e costo del venduto, diviso per ricavo ed espresso in percentuale.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Margine lordo di aziende nel Health Care settore su NASDAQ rispetto a Edesa Biotech

Cosa fa Edesa Biotech?

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.

Aziende con margine lordo simili a Edesa Biotech